Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Reference

PAR-25-069

Agency

National Institutes of Health

Posted

2024-11-18

Deadline

2027-01-07

Source status

posted at retrieval

Country

United States (funding region); applicant eligibility varies

Listing numbers

93.393

Retrieved

2026-11-10T18:56:52.593Z

Read the official call before applying

Check the full description, funding amounts, eligibility, required documents and any amendments with the official funder. Additional restrictions and application instructions may not be included in this directory.